Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BEBT-701 in Mild to Moderate Hypertension and Elevated LDL-C
NCT07368608Phase 2Recruiting
- Sponsor
- BeBetter Med
- Start
- Mar 2026
- Primary completion
- Nov 2028
- Countries
- 1
01
Overview
A Phase 2 trial of BEBT-701 in hypertension (HTN), hypercholesterolemia, sponsored by BeBetter Med. Started Mar 2026; status: recruiting.
02
Drugs
BEBT-701
03
Conditions
hypertension (HTN)hypercholesterolemia
Beyond the preview
Go deeper on NCT07368608.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07368608.